Altered Expression of BCRP Impacts Fetal Accumulation of Rosuvastatin in a Rat Model of Preeclampsia
Expression of the breast cancer resistance protein (BCRP/ABCG2) transporter is downregulated in placentas from women with preeclampsia (PE) and in an immunological rat model of PE. While many drugs are substrates of this important efflux transporter, the impact of PE associated BCRP downregulation o...
Saved in:
Main Authors: | Wanying Dai (Author), Micheline Piquette-Miller (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of Viral Inflammation on the Expression of Renal Drug Transporters in Pregnant Rats
by: Navaz Karimian Pour, et al.
Published: (2019) -
Endotoxin Modulates the Expression of Renal Drug Transporters in HIV-1 Transgenic Rats
by: Navaz Karimian Pour, et al.
Published: (2018) -
Expression of ABCG2 (BCRP) in mouse models with enhanced erythropoiesis
by: Gladys Oluyemisi Latunde-Dada, et al.
Published: (2014) -
Clinical Assessment of Breast Cancer Resistance Protein (BCRP)-Mediated Drug-Drug Interactions of Sepiapterin with Curcumin and Rosuvastatin in Healthy Volunteers
by: Lan Gao, et al.
Published: (2024) -
The Role of PXR Genotype and Transporter Expression in the Placental Transport of Lopinavir in Mice
by: Sarabjit S. Gahir, et al.
Published: (2017)